Cellular Biomedicine Group - Results from AlloJoin Phase I
In March 2018, Cellular Biomedicine Group (CBMG) announced results from the Phase I study of AlloJoin for knee osteoarthritis (KOA). The primary...
80 Views
Cell therapy for China and the US
We are initiating coverage on Cellular Biomedicine Group (CBMG), a trans-Pacific cell therapy company developing products in China and the US. It...
85 Views
A transpacific cell therapy company
Cellular Biomedicine Group (CBMG) has seven preclinical CAR-T programs and two Phase I clinical trials using its CD19 CAR-T therapy in China,...
91 Views
No more insights